Skip to main content

Neurodegenerative Disorder Therapeutics Market is Predicted to Grow at a CAGR of 7.21% by 2030

 The global market for neurodegenerative disorder therapeutics is predicted to grow at a CAGR of 7.21% over the forecast period of 2020-2030. The market is driven by certain factors, which include the increasing global geriatric population, increasing incidence of chronic diseases including neurodegenerative disorder, and the presence of high unmet clinical needs regarding treatment for immune disorders, and significant external funding for executing R&D exercises.

The market is favored by the development of neurodegenerative disorder therapeutics for several clinical areas such as Multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, Spinal Muscular Atrophy, Huntington disease, and other neurodegenerative disorders. The increase in the geriatric population and incurable neurodegenerative disorders across the globe are expected to translate into significantly higher demand for neurodegenerative disorder therapeutics market. 


Furthermore, the companies are investing huge amounts in research and development of neurodegenerative disorder therapeutics either as a monotherapy or as combination therapy. The clinical trial landscape of different neurodegenerative disorders has been on the rise in recent years, and this will fuel the neurodegenerative disorder therapeutics market in the future.

The exponential rise in the application of precision medicine on a global level has created a buzz among companies to invest in the development of novel neurodegenerative disorder therapeutics. Due to the diverse product portfolio and intense market penetration, Biogen Inc. has been a pioneer in this field and has been a significant competitor in this market.

Several other companies such as Novartis AG, F. Hoffmann- La Roche Ltd., and Bristol Myers Squibb Company, among others, have launched therapies for neurodegenerative disorder, such as Mayzent (siponimod), Ocrevus (ocrelizumab), and Zeposia (ozanimod) respectively, to compete with Biogen Inc.’s Tecfidera (dimethyl fumarate) therapy market dominance.

Based on region, North America holds the largest share of neurodegenerative disorder therapeutics market due to improved healthcare infrastructure, rise in per capita income, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.

Key Questions Answered in this Report:

•    What are the various neurodegenerative disorder therapeutics available in the market?
•    What are emerging therapies for the treatment of neurodegenerative disorders?
•    How does the pipeline for global neurodegenerative disorder therapeutics market look like? 
•    What is the current market size and future potential of these therapies? 
•    What are the major market drivers, challenges, and opportunities in the global neurodegenerative disorder therapeutics market?
•    What mechanisms of action and molecules are being trialed most commonly in pipeline products? 
•    Which products will contribute most significantly to the market growth, and which will achieve blockbuster status? 
•    How does the clinical landscape look for the neurodegenerative disorder therapeutics market?
•    What is the status of biosimilars in this market?
•    What is the patent landscape of this market? What will be the impact of patent expiry on this market?
•    What is the reimbursement scenario of the available therapeutics in this market?
•    What will be the impact of COVID-19 on this market?
•    What is the mechanism of action of various neurodegenerative disorder therapeutics available in the market?
•    What will be the impact of digitalization on this market? 
•    What are the guidelines implemented by different government bodies to regulate the approval of neurodegenerative disorder therapeutics? 
•    What are the key technological developments on which the current industry leaders are spending a major share of their research and development (R&D) investments?
•    Which leading players currently hold dominant shares in the global neurodegenerative disorder therapeutics market?
•    What are the key strategies incorporated by the players of the global neurodegenerative disorder therapeutics market to sustain the competition and retain their supremacy?
•    What is the current revenue contribution of the global neurodegenerative disorder therapeutics market (by product type), and how would it evolve in the forecast period?
•    What is the current revenue contribution of the global neurodegenerative disorder therapeutics market (by drug class), and how would it evolve in the forecast period?
•    What is the current revenue contribution of the global neurodegenerative disorder therapeutics market (by indication), and how would it evolve in the forecast period?
•    What is the current revenue contribution of the global neurodegenerative disorder therapeutics market (by route of administration), and how would it evolve in the forecast period?
•    Which region is expected to contribute the highest revenue to the global neurodegenerative disorder therapeutics market during the forecast period?

Request a Sample - https://bisresearch.com/requestsample?id=994&type=download

Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: •     Industry Analysis    ...
Post a Comment
Read more

Hyperspectral Imaging Market Projections , Upcoming Trends Focus on Long-Term Impact of Covid-19 and Forecast By 2027

  The global  hyperspectral imaging market  was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining. The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases.   COVID-19 Impact and Post-COVID-19 Scenario The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on se...
Post a Comment
Read more